[Reactivation of hepatitis B after cessation of Rituximab monotherapy]

Gastroenterol Clin Biol. 2006 Dec;30(12):1417-8. doi: 10.1016/s0399-8320(06)73575-8.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage*
  • Hepatitis B / etiology*
  • Humans
  • Male
  • Middle Aged
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab